NEW YORK (GenomeWeb News) - Transgene said today that the French Agency for Industrial Innovation has awarded it €25 million ($32.7 million) to participate in a pharmacogenomics project called ADNA (Advanced Diagnostics and New therapeutic Approaches).
 
ADNA includes four partners -- Transgene, bioMerieux, Genethon, and GenoSafe -- and aims to improve personalized medicine in the fields of cancer, infectious diseases, and rare genetic diseases.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

23andMe's Anne Wojcicki ponders DNA and what it means to be human in a New York Times essay.

A new estimate places the last universal common ancestor to life on Earth as living 3.9 billion years ago, Inverse reports.

In PNAS this week: retinitis pigmentosa gene therapy, role of microbiome in growth stunting, and more.

Bloomberg reports that researchers and drug companies are modeling anti-obesity treatments after the rare genetic condition essential fructosuria.